Prognostic value of receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF1-R), and somatostatin (SS-R), and of PS2 protein, in patients with breast and ovarian cancer : J.A. Foekens, W.L.J. van Putten, H. Portengen, C.J. Rodenburg, J-C. Reubi, S.C. Henzen-Logmans, J. Alexieva-Figusch and J.G.M. Klijn. Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands

doi:10.1016/0277-5379(90)90326-o

Prognostic value of receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF1-R), and somatostatin (SS-R), and of PS2 protein, in patients with breast and ovarian cancer : J.A. Foekens, W.L.J. van Putten, H. Portengen, C.J. Rodenburg, J-C. Reubi, S.C. Henzen-Logmans, J. Alexieva-Figusch and J.G.M. Klijn. Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands

https://doi.org/10.1016/0277-5379(90)90326-o

Copy DOI

Journal: European journal of cancer & clinical oncology

Publication Date: Feb 1, 1990

#Daniel Den Hoed Cancer Center #Receptors For Epidermal Growth Factor + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Prognostic value of receptors for epidermal growth factor (EGF-R), insulin-like growth factor-1 (IGF1-R), and somatostatin (SS-R), and of PS2 protein, in patients with breast and ovarian cancer : J.A. Foekens, W.L.J. van Putten, H. Portengen, C.J. Rodenburg, J-C. Reubi, S.C. Henzen-Logmans, J. Alexieva-Figusch and J.G.M. Klijn. Dr. Daniel den Hoed Cancer Center, Rotterdam, The Netherlands

Full Text